ZENAIDA VIVAR: Open Payments
NPI 1487780516 · PALOS HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$638 in 31 payments from 12 companies in 2025. Trend: 2023 $1,105 · 2024 $1,282 · 2025 $638
Food & beverage: $638
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $79 |
| ABBVIE INC. | 3 | $73 |
| Corium, LLC | 3 | $60 |
| Vanda Pharmaceuticals Inc. | 3 | $58 |
| Bausch Health US, LLC | 3 | $49 |
| Alkermes, Inc. | 2 | $41 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: Auvelity, CAPLYTA, VRAYLAR, Azstarys, FANAPT, APLENZIN, LYBALVI, REXULTI.
Industry payments across IL — which companies pay providers there.
